Continued progression of retinopathy despite spontaneous recovery to normoglycemia in a long-term study of streptozotocin-induced diabetes in rats

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 238, Issue 2, 2000, Pages 163-173

  Su , Er Ning ^a   Alder, Valerie A ^a   Yu, Dao Yi ^a   Yu, Paula K ^b   Cringle, Stephen J ^b   Yogesan, Kanagasingam ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRYPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MICROANEURYSM; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA BLOOD VESSEL; RETINA CAPILLARY; STREPTOZOCIN DIABETES;

EID: 0034102652     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050028     Document Type: Article

References (28)

1. Ashton N (1963) Studies of the retinal capillaries in relation to diabetic and other retinopathies. Br J Ophthalmol 47: 521-538
2. Bucala R, Cerami A (1992) Advanced glycosylation: chemistry, biology, and implication for diabetes and aging. Adv Pharmacol 23: 1-34
3. Bucala R, Model P, Cerami A (1984) Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression. Proc Natl Acad Sci USA 81:105-109
4. Chakrabarti S, Sima SS, Tze WJ, Tai J (1987) Prevention of diabetic retinal capillary pericyte degeneration and loss by pancreatic islet allograft. Corr Eye Res 6: 649-658
5. Cogan DG, Toussaint D, Kuwabara T (1961) Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66: 366-378
6. Cringle SJ, Yu D-Y, Alder VA, Su E-N (1993) Retinal blood flow by hydrogen clearance polarography in the STZ-induced diabetic rat. Invest Ophthalmol Vis Sci 34:1716-1721
7. DCCT Research Group (1995) Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 102:647-661
8. Engerman RL, Kern TS (1987) Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36: 808-812
9. Engerman RL, Kern TS (1995) Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. Arch Ophthalmol 113: 355-358
10. Hammes H-P, Martin S, Federlin K, Geisen K, Brownlee M (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci 88: 11555-11558
11. Iwase M (1991) A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats. Fukuoka Igaku Zasshi Fukuoka Acta Med 82: 415-427
12. Iwase M Nunoi K, Wakisaka M, Kikuchi M, Maki Y, Sadoshima S, Fujishima M (1991) Spontaneous recovery from non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin treatment in spontaneously hypertensive rats. Metab Clin Exp 40: 10-14
13. Kern TS, Engerman RL (1995) Galactose-induced microanagiopathy in rats. Invest Ophthalmol Vis Sci 36: 490-496
14. Kern TS, Engerman RL (1995) Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp Eye Res 60: 545-549
15. Kern TS, Engerman RL (1994) Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. Curr Eye Res 13: 863-867
16. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Edipemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526
17. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Edipemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 520-526
18. Kojima K, Matsubara H, Harada T, Mizuno K, Suzuki M, Hotta N, Kakuta H, Sakamoto N (1985) Effects of aldose reductase inhibitor on retinal microangiopathy. Jpn J Ophthalmol 29: 99-109
19. Kuwabara T, Cogan DG (1960) Studies of retinal vascular patterns. Arch Ophthalmol 64: 904-911
20. Leuenberger P, Cameron D, Stauffacher W, Renold AE, Babel J (1971) Ocular lesions in rats rendered chronically diabetic with streptozotocin. Ophthalmic Res 2: 189-204
21. Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193: 415-417
22. Papachristodoulou D, Heath H, Kang SS (1976) The development of retinopathy in sucrose-fed and streptozotocin rats. Diabetologia 12: 367-74
23. Robison Jr WG, Laver NM, Jacot JL, Glover JP (1995) Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model. Invest Ophthalmol Vis Sci 36:2368-2380
24. Robison Jr WG, McCaleb ML, Feld LG, Michaelis IV, OE, Laver N, Mercandetti M (1991) Degenerated intramural pericytes ('ghost cells') in the retinal capillaries of diabetic rats. Curr Eye Res 10: 339-350
25. Schmidt FH, Siegel EG, Trapp VE (1980) Metabolic and hormonal investigations in long-term streptozotocin diabetic rats on different dietary regimens. Diabetologia 18: 161-168
26. Sharma NK, Gardiner TA, Archer DB (1985) A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. Am J Ophthalmol 100: 51-60
27. Su E-N, Yu D-Y, Alder VA, Yu PK, Cringle SJ (1995) Altered vasoactivity in the early diabetic eye: measured in the isolated perfused rat eye. Exp Eye Res 61:699-712
28. Yu D-Y, Cringle SJ, Alder VA, Su E-N (1994) Intraretinal oxygen distribution in the rat as a function of systemic blood pressure. Am J Physiol 267 (Heart Circul Physiol) 36:H2498-H2507